Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Comparing balloon and self-expanding valves for heart valve replacement

Official title: Balloon Expandable vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis. THE BASELINE TRIAL.

Run by Erasmus Medical Center · NCT04843072 · Data updated 2026-11-12

This study is testing whether balloon-expandable or self-expanding heart valves work better for older patients needing a replacement due to a failed heart valve.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations14 sites (Los Angeles, California and 13 other locations)
StatusRecruiting
StartedMay 1, 2021
Main results expectedJune 1, 2028
Study endsMay 1, 2029
Registry record updatedOctober 13, 2026
Trial IDNCT04843072 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 65 and older with failing surgical aortic bioprostheses who are eligible for transfemoral TAVI.

Probably not a fit

Patients with multi-valve defects, unstable clinical conditions, or those with a mechanical aortic valve will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of balloon expandable versus self-expanding transcatheter heart valves in patients with degenerated surgical aortic bioprostheses. It focuses on elderly patients who require valve replacement due to bioprosthesis failure, utilizing a transfemoral TAVI approach. The study aims to assess the safety and efficacy of these two valve types in preventing complications associated with valve replacement. Participants will be selected based on multi-modality imaging assessments and heart team consensus.

Why it matters

Potential benefit: If successful, this study could provide a safer and more effective treatment option for elderly patients with degenerated aortic bioprostheses.

How similar studies have gone: Other studies have shown promising results with transcatheter aortic valve implantation in similar patient populations, indicating that this approach is both effective and increasingly utilized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Failing surgical aortic bioprosthesis requiring valve replacement and eligible for transfemoral TAVI with balloon expandable or self-expanding platform per heart team consensus based on multi-modality imaging assessment (including echocardiography and multidetector CT).
* Written informed consent

Exclusion Criteria:

* Not eligible for Transfemoral TAVI with EVOLUT, SAPIEN or MYVAL THV series
* Multi-valve defects requiring intervention
* Clinically unstable and/or inotropic/vasopressor /mechanical support.
* Known mural thrombus in the left ventricle
* Presence of a mechanical aortic valve
* History of recent (within 1 month) stroke or TIA

Where it's running

  • Cedars Sinai
    Los Angeles, California, United States
    Recruiting
  • Vienna General Hospital
    Vienna, Austria
    Recruiting
  • Institut Cœur Poumon
    Lille, France
    Recruiting
  • Division of Cardiology, Pulmonology, and Vascular Medicine, Heinrich Heine University Medical Center Dusseldorf, Dusseldorf, Germany
    Düsseldorf, Germany
    Recruiting
  • Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece
    Athens, Greece
    Recruiting
  • Interventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Institute, Brescia, Italy
    Brescia, Italy
    Recruiting
Show 8 more locations
  • Erasmus Medical Centre
    Rotterdam, Netherlands
    Recruiting
  • Centro Hospitalar de Lisboa Ocidental
    Lisbon, Portugal
    Recruiting
  • St Paul's and Vancouver General Hospital
    Vancouver, Canada
    Not yet recruiting
  • Rigshospitalet
    Copenhagen, Denmark
    Not yet recruiting
  • University Hospital Mainz
    Mainz, Germany
    Not yet recruiting
  • University Hospital of Padova
    Padua, Italy
    Not yet recruiting
  • Inselspital, University Hospital
    Bern, Switzerland
    Not yet recruiting
  • Leeds Teaching Hospitals
    Leeds, United Kingdom
    Not yet recruiting

Study contacts

  • Principal investigator: Nicolas Van Mieghem, MD, PhD — Erasmus Medical Centre
  • Study coordinator: Rutger-Jan Nuis, MD, PhD
  • Email: r.nuis@erasmusmc.nl
  • Phone: +31614858291

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Prospective cardiac surgery cohort to improve perioperative care

    A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07662317

  • Effects of Myofascial Release on Heart Patients After Sternotomy

    This study tests whether myofascial release can improve breathing and chest mobility after heart surgery in adults with certain heart diseases.

    Recruiting Kaohsiung Veterans General Hospital. · Kaohsiung City · NCT07649330

  • Characterizing patients and outcomes in severe tricuspid regurgitation

    This study looks at people with severe tricuspid regurgitation to see who can get a new heart valve treatment and how well it works for them.

    Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT06838611

  • Transplanting heart valves from donors into patients who need them

    This study is testing if heart valves from donors can help kids and young adults who need valve replacements by providing a solution that grows with them and reduces the need for more surgeries later on.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06387446

  • Using AI to improve heart disease management in rural Australia

    This study is testing whether using artificial intelligence to help with heart scans can improve care for people with heart problems living in rural Australia.

    Recruiting Baker Heart and Diabetes Institute · Alice Springs, Northern Territory · NCT05558605

  • Comparing imaging methods for heart valve disease assessment

    This study is testing whether a new 3D heart imaging method is better than the traditional 2D method for checking how serious heart valve problems are in people with conditions like aortic stenosis and mitral valve regurgitation.

    Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT04126018

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.